Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs

Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission. The post Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare…

Read More

Are you ready for Open Enrollment?

Open Enrollment for 2025 Marketplace coverage starts November 1.  Open Enrollment is right around the corner. Make sure you’re ready.  Image Did you: Gather basic information (PDF, 163 KB)? You can fill out your application faster if you’re ready with information like birthdates and Social Security Numbers (SSNs).Check to see if you might save on…

Read More

6 HIMSS Announcements You Don’t Want to Miss

This year’s HIMSS conference featured many news announcements — from advanced partnerships to product launches to new research. In this list, MedCity News compiled short summaries for six of the conference’s most notable announcements. The post 6 HIMSS Announcements You Don’t Want to Miss appeared first on MedCity News.

Read More

CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System

CMS is rolling out its health tech ecosystem initiative with a new Medicare app library that functions like a healthcare “App Store,” aiming to make patient data more portable and accessible across vetted digital health apps. The post CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System appeared first…

Read More